Sports Physical Therapy
Conditions
Keywords
sports, recovery, intermittent pneumatic compression
Brief summary
The aim of this randomized crossover trial is to assess the hemodynamic effects caused by the use of 2 distinct intermittent pneumatic compression protocols on athletes. The main questions it aims to answer are: * Does intermittent pneumatic compression enhance athletes blood flow? * If yes, what pressure is better to cause this enhancement?
Interventions
DEVICEIntermittent pneumatic compression (AirRelax)
Moderate pressure (around 80mmHg); high pressure (around 200mmHg), both applied on the lower-limbs
Sponsors
University of Maia
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
18 Years to 26 Years
Healthy volunteers
Yes
Inclusion criteria
* male gender * healthy * competing in soccer of track and field for at least two years * not have performed any physical activity on the data collection day
Exclusion criteria
* more than one risk factor for thromboembolism (e.g., use of tobacco, varicose veins) * injured athletes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Arterial Diameter | 2 minutes before the IPC protocol, during (8th minute mark), and 2 minutes after the conclusion of the 15 minute protocol. | Assessment of arterial diameter via automatic edge detection software (FMD Studio, Pisa, Italy) measuring the distance between the near and far wall of the intima |
| End-diastolic peak velocity | 2 minutes before the IPC protocol, during (8th minute mark - at different phases of the IPC cycle), and 2 minutes after the conclusion of the 15 minute protocol. | End-diastolic peak velocity will be assessed in a supine position on the right common femoral artery using an ultrasound (Logiq e BT12; General Electric, Fairfield, CT, USA) with a 3 to 12 MHz multi-frequency linear phase array transducer. |
| Systolic peak velocity | 2 minutes before the IPC protocol, during (8th minute mark - at different phases of the IPC cycle), and 2 minutes after the conclusion of the 15 minute protocol. | Systolic peak velocity will be assessed in a supine position on the right common femoral artery using an ultrasound (Logiq e BT12; General Electric, Fairfield, CT, USA) with a 3 to 12 MHz multi-frequency linear phase array transducer. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Heart rate | 2 minutes before the IPC protocol, during (8th minute mark - at different phases of the IPC cycle), and 2 minutes after the conclusion of the 15 minute protocol. | Assess any changes in heart rate. |
Countries
Portugal
Outcome results
None listed